Outcomes after donor stem cell transplant
Part of Blood & lymphatic clinical trials.
This study looks at how well patients do after receiving a stem cell transplant from a donor (called an allogeneic transplant). It aims to better understand the long-term outcomes and help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have already received a stem cell transplant from a donor (not from yourself).
- You must be able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and teens who get a stem cell transplant to learn how lung problems develop over time. Your participation could help doctors better predict, prevent, and manage lung injury after transplant.
This study looks at how a genetic risk factor in a stem cell donor (called CHIP) may affect outcomes after an allogeneic (donor-to-recipient) stem cell transplant. It may help doctors better predict which donor factors are important for patient outcomes.
This study looks at how children who received a stem cell transplant at one hospital are doing. It aims to learn about their recovery and long-term results, which can help improve care for future patients.
This study looks at whether a rehabilitation and exercise program can help people recover after an allogeneic stem cell transplant. It aims to improve your recovery and quality of life after the transplant.
This study follows patients who have received a stem cell transplant from a donor to track and understand fungal infections that can occur afterward. By studying this carefully, researchers hope to better prevent and treat these serious infections in future patients.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
Hear when a new Hematopoietic Stem Cell Transplant (HSCT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.